Electron transfer partners of cytochrome P450

Cytochrome P450: Structure, Mechanism, and Biochemistry, Fourth Edition

Volumn , Issue , 2015, Pages 33-68

  Waskell, Lucy ^a   Kim, Jung Ja P ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adrenodoxin; Adrenodoxin reductase; Allosteric effect; Antley Bixler syndrome; Connecting domain (CD); Cytochrome; Cytochrome b5; Domain movement; Domain structure; Electron transfer; Electron transfer partner; Endoplastic reticulum; FAD domain; Ferredoxin; Ferredoxin reductase; Flavin; FMN domain; Hydride transfer; Membrane binding; Membrane binding domain (MBD); NMR; P450 oxidoreductase (POR, CPR); POR (CPR) deficiency; Protein protein interaction

Indexed keywords

EID: 84945132778     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-12108-6_2     Document Type: Chapter

References (208)

1. Guengerich FP (2008) Cytochrome P450 and chemical toxicology Chem Res Toxicol 21:70-83
2. Roman LJ, Masters BS (2010) The cytochromes P450 and nitric oxide synthases In: Devlin TM (ed) Textbook of biochemistry with clinical correlations, 7th edn Wiley, New York, pp 425-456
3. Hannemann F, Bichet A, Ewen KM, Bernhardt R (2007) Cytochrome P450 systems-biological variations of electron transport chains Biochim Biophys Acta 1770:330-344
4. Stuehr DJ, Tejero J, Haque MM (2009) Structural and mechanistic aspects of flavoproteins: electron transfer through the nitric oxide synthase flavoprotein domain FEBS J 276:3959-3974
5. Daff S (2010) NO synthase: structures and mechanisms Nitric Oxide Biol Chem 23:1-11
6. Feng C (2012) Mechanism of nitric oxide synthase regulation: electron transfer and interdomain interactions Coord Chem Rev 256:393-411
7. Iyanagi T, Xia C, Kim JJ (2012) NADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family Arch Biochem Biophys 528:72-89
8. Ruettinger RT, Wen LP, Fulco AJ (1989) Coding nucleotide, 5ʹ regulatory, and deduced amino acid sequences of P-450BM-3, a single peptide cytochrome P-450:NADPH-P-450 reductase from Bacillus megaterium J Biol Chem 264:10987-10995
9. Ostrowski J, Barber MJ, Rueger DC, Miller BE, Siegel LM, Kredich NM (1989) Characterization of the flavoprotein moieties of NADPH-sulfite reductase from Salmonella typhimurium and Escherichia coli Physicochemical and catalytic properties, amino acid sequence deduced from DNA sequence of cysJ, and comparison with NADPH-cytochrome P-450 reductase J Biol Chem 264:15796-15808
10. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HH, Rommens JM, Scherer SW, Rosenblatt DS, Gravel RA (1998) Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria Proc Natl Acad Sci U S A 95:3059-3064
11. Olteanu H, Benerjee R (2001) Human methionine synthase reductase, a soluble P450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation J Biol Chem 276:35558-35563
12. Wolthers KR, Lou X, Toogood HS, Leys D, Scrutton NS (2007) Mechanism of coenzyme binding to human methionine synthase reductase revealed through the crystal structure of the FNR-like module and isothermal titration calorimetry Biochemistry 46:11833- 11844
13. Paine MJ, Garner AP, Powell D, Sibbald J, Sales M, Pratt N, Smith T, Tew DG, Wolf CR (2000) Cloning and characterization of a novel human dual flavin reductase J Biol Chem 275:1471-1478
14. Inui H, Yamaji R, Saidoh H, Miyatake K, Nakano Y, Kitaoka S (1991) Pyruvate:NADP+ oxidoreductase from Euglena gracilis: limited proteolysis of the enzyme with trypsin Arch Biochem Biophys 286:270-276
15. Nakazawa M, Inui H, Yamaji R, Yamamoto T, Takenaka S, Ueda M, Nakano Y, Miyatake K (2000) The origin of pyruvate: NADP+ oxidoreductase in mitochondria of Euglena gracilis FEBS Lett 479:155-156
16. Netz DJ, Stumpfig M, Dore C, Muhlenhoff U, Pierik AJ, Lill R (2010) Tah18 transfers electrons to Dre2 in cytosolic iron-sulfur protein biogenesis Nat Chem Biol 6:758-765
17. Schacter BA, Nelson EB, Marver HS, Masters BS (1972) Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system J Biol Chem 247:3601-3607
18. 5 by NADPH-cytochrome P450 reductase Arch Biochem Biophys 440:204-211
19. Ono T, Takahashi K, Odani S, Konno H, Imai Y (1980) Purification of squalene epoxidase from rat liver microsomes Biochem Biophys Res Comm 96:522- 528
20. 5 and methylene blue Biochemistry 49:2647-2656
21. Petersen JA, Ebel RE, O'Keeffe DH, Matsubara T, Estabrook RW (1976) Temperature dependence of cytochrome P-450 reduction A model for NADPHcytochrome P-450 reductase:cytochrome P-450 interaction J Biol Chem 251:4010-4016
22. Shephard EA, Phillips IR, Bayney RM, Pike SF, Rabin BR (1983) Quantification of NADPH: cytochrome P-450 reductase in liver microsomes by a specific radioimmunoassay technique Biochem J 211:333- 340
23. Backes WL, Kelley RW (2003) Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes Pharmacol Ther 98:221-233
24. Johnson EF, Stout CD (2005) Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases Biochem Biophys Res Comm 338:331-336
25. Johnson EF, Stout CD (2013) Structural diversity of eukaryotic membrane cytochrome P450s J Biol Chem 288:17082-17090
26. Iyanagi T, Mason HS (1973) Some properties of hepatic reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase Biochemistry 12:2297-2308
27. Iyanagi T, Makino R, Anan FK (1981) Studies on the microsomal mixed-function oxidase system: mechanism of action of hepatic NADPH-cytochrome P-450 reductase Biochemistry 20:1722-1730
28. 5 reductases Biochemistry 13:1701-1710
29. Das A, Sligar SG (2009) Modulation of the cytochrome P450 reductase redox potential by the phospholipid bilayer Biochemistry 48:12104-12112
30. Brenner S, Hay S, Munro AW, Scrutton NS (2008) Inter-flavin electron transfer in cytochrome P450 reductase-effects of solvent and pH identify hidden complexity in mechanism FEBS J 275:4540-4557
31. Munro AW, Noble MA, Robledo L, Daff SN, Chapman SK (2001) Determination of the redox properties of human NADPH-cytochrome P450 reductase Biochemistry 40:1956-1963
32. Vermilion JL, Coon MJ (1978) Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase J Biol Chem 253(24):8812-8819
33. Oprian DD, Coon MJ (1982) Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH J Biol Chem 257:8935-8944
34. Oprian DD, Gorsky LD, Coon MJ (1983) Properties of the oxygenated form of liver microsomal cytochrome P-450 J Biol Chem 258:8684-8691
35. Porter TD, Kasper CB (1986) NADPH-cytochrome P-450 oxidoreductase: flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins. Biochemistry 25:682-1687
36. Wang M, Roberts DL, Paschke R, Shea TM, Masters BS, Kim JJ (1997) Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes Proc Natl Acad Sci U S A 94:8411-8416
37. Karplus PA, Daniels MJ, Herriott JR (1991) Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family. Science 251:60-66
38. Smith GC, Tew DG, Wolf CR (1994) Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains Proc Natl Acad Sci U S A 91:8710-8714
39. Hodgson AV, Strobel HW (1996) Characterization of the FAD binding domain of cytochrome P450 reductase Arch Biochem Biophys 325:99-106
40. Garcin ED, Bruns CM, Lloyd SJ, Hosfield DJ, Tiso M, Gachhui R, Stuehr DJ, Tainer JA, Getzoff ED (2004) Structural basis for isozyme-specific regulation of electron transfer in nitric-oxide synthase J Biol Chem 279:37918-37927
41. Black SD, Coon MJ (1982) Structural features of liver microsomal NADPH-cytochrome P-450 reductase Hydrophobic domain, hydrophilic domain, and connecting region J Biol Chem 257:5929-5938
42. Porter TD, Kasper CB (1985) Coding nucleotide sequence of rat NADPH-cytochrome P-450 oxidoreductase cDNA and identification of flavin-binding domains Proc Natl Acad Sci U S A 82:973-977
43. Taniguchi H, Imai Y, Iyanagi T, Sato R (1979) Interaction between NADPH-cytochrome P-450 reductase and cytochrome P-450 in the membrane of phosphatidylcholine vesicles Biochim Biophys Acta 550:341-356
44. Black S, French JS, Williams JH Jr, Coon MJ (1979) Role of a hydrophobic polypeptide in the N-terminal region of NADPH-cytochrome P-450 reductase in complex formation with P-450LM Biochem Biophys Res Comm 91:1528-1535
45. Cojocaru V, Balali-Mood K, Sansom MS, Wade RC (2012) Structure and dynamics of the membranebound cytochrome P450 2C9 PLoS Comput Biol 7: e1002152
46. 5 Biochem Biophys Res Comm 284:937-941
47. Venkateswarlu K, Lamb DC, Kelly DE, Manning NJ, Kelly SL (1998) The N-terminal membrane domain of yeast NADPH-cytochrome P450 CYP, oxidoreductase is not required for catalytic activity in sterol biosynthesis or in reconstitution of CYP activity J Biol Chem 273:4492-4496
48. Blanck J, Smettan G, Ristau O, Ingelman-Sundberg M, Ruckpaul K (1984) Mechanism of rate control of the NADPH-dependent reduction of cytochrome P-450 by lipids in reconstituted phospholipid vesicles Eur J Biochem 144:509-513
49. Vermilion JL, Ballou DP, Massey V, Coon MJ (1981) Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase J Biol Chem 256:266-277
50. Shen AL, Porter TD, Wilson TE, Kasper CB (1989) Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by sitedirected mutagenesis J Biol Chem 264:7584-7589
51. Marohnic CC, Panda SP, McCammon K, Rueff J, Masters BS, Kranendonk M (2010) Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect Drug Metab Disp 38:332-340
52. Nicolo C, Fluck CE, Mullis PE, Pandey AV (2010) Restoration of mutant cytochrome P450 reductase activity by external flavin. Mol Cell Endo 321:245- 252
53. Hamdane D, Xia C, Im SC, Zhang H, Kim JJ, Waskell L (2009) Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450 J Biol Chem 284:11374-11384
54. 5 and cytochrome P450 reductase J Biol Chem 273:17036- 17049
55. 5 Arch Biochem Biophys 507:144-153
56. Johnson EF, Wester MR, Stout CD (2002) The structure of microsomal cytochrome P450 2C5: a steroid and drug metabolizing enzyme Endo Res 28:435-441
57. Nisimoto Y (1986) Localization of cytochrome c-binding domain on NADPH-cytochrome P-450 reductase J Biol Chem 261:14232-14239
58. 5, cytochrome c, and cytochrome P-450 interactions with NADPH cytochrome P-450 reductase in phospholipid vesicles Biochemistry 27:5869-5876
59. Shen AL, Kasper CB (1995) Role of acidic residues in the interaction of NADPH-cytochrome P450 oxidoreductase with cytochrome P450 and cytochrome c J Biol Chem 270:27475-27480
60. Strobel HW, Hodgson AV, Shen SJ (1995) NADPH cytochrome P450 reductase and its structural and functional domains In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biocheimstry, 2nd edn Plenum, New York
61. Jang HH, Jamakhandi AP, Sullivan SZ, Yun CH, Hollenberg PF, Miller GP (2010) Beta sheet 2-alpha helix C loop of cytochrome P450 reductase serves as a docking site for redox partners Biochim Biophys Acta 1804:1285-1293
62. Hlavica P, Schulze J, Lewis DFV (2003) Functional interaction of cytochrome P450 with its redox partners: a critical assessment and update of the topology of predicted contact regions J Inorg Biochem 96:279- 297
63. Huang WC, Ellis J, Moody PC, Raven EL, Roberts GC (2013) Redox-linked domain movements in the catalytic cycle of cytochrome P450 reductase Structure 21:1581-1589
64. Kenaan C, Zhang H, Shea EV, Hollenberg PF (2011) Uncovering the role of hydrophobic residues in cytochrome P450-cytochrome P450 reductase interactions Biochemistry 50:3957-3967
65. Miwa GT, West SB, Huang MT, Lu AY (1979) Studies on the association of cytochrome P-450 and NADPH cytochrome c reductase during catalysis in a reconstituted hydroxylating system J Biol Chem 254:5695- 5700
66. Jamakhandi AP, Kuzmic P, Sanders DE, Miller GP (2007) Global analysis of protein-protein interactions reveals multiple CYP2E1-reductase complexes Biochemistry 46:10192-10201
67. Reed JR, Cawley GF, Backes WL (2011) Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-in rat liver microsomes Drug Metab Lett 5:6-16
68. Kurzban GP, Strobel HW (1986) Purification of flavin mononucleotide-dependent and flavin-adenine dinucleotide- dependent reduced nicotinamide-adenine dinucleotide phosphate-cytochrome P-450 reductase by high-performance liquid chromatography on hydroxyapatite J Chromatogr 358:296-301
69. Narayanasami R, Nishimura JS, McMillan K, Roman LJ, Shea TM, Robida AM, Horowitz PM, Masters BS (1997) The influence of chaotropic reagents on neuronal nitric oxide synthase and its flavoprotein module. Urea and guanidine hydrochloride stimulate NADPHcytochrome c reductase activity of both proteins Nitric oxide Biol Chem 1:39-49
70. Narayanasami R, Horowitz PM, Masters BS (1995) Flavin-binding and protein structural integrity studies on NADPH-cytochrome P450 reductase are consistent with the presence of distinct domain Arch Biochem Biophys 316:267-274
71. Shen AL, Kasper CB (2000) Differential contributions of NADPH-cytochrome P450 oxidoreductase FAD binding site residues to flavin binding and catalysis. J Biol Chem 275:41087-41091
72. Shen AL, Kasper CB (1996) Role of Ser457 of NADPH-cytochrome P450 oxidoreductase in catalysis and control of FAD oxidation-reduction potential Biochemistry 35:9451-9459
73. Shen AL, Sem DS, Kasper CB (1999) Mechanistic studies on the reductive half-reaction of NADPHcytochrome P450 oxidoreductase J Biol Chem 274:5391-5398
74. Hubbard PA, Shen AL, Paschke R, Kasper CB, Kim JJ (2001) NADPH-cytochrome P450 oxidoreductase: structural basis for hydride and electron transfer J Biol Chem 276:29163-29170
75. Deng Z, Aliverti A, Zanetti G, Arakaki AK, Ottado J, Orellano EG, Calcaterra NB, Ceccarelli EA, Carrillo N, Karplus PA (1999) A productive NADP+ binding mode of ferredoxin-NADP+ reductase revealed by protein engineering and crystallographic studies Nat Struct Biol 6:847-853
76. +/H Biochemistry 44:13477-13490
77. Sem DS, Kasper CB (1993) Interaction with arginine of NADPH-cytochrome P-450 oxidoreductase is a primary source of the uniform binding energy used to discriminate between NADPH and NADH Biochemistry 32:11548-11558
78. Gutierrez A, Doehr O, Paine M, Wolf CR, Scrutton NS, Roberts GC (2000) Trp676 facilitates nicotinamide coenzyme exchange in the reductive half-reaction of human cytochrome P450 reductase: properties of the soluble W676H and W676A mutant reductases Biochemistry 39:15990-15999
79. Elmore CL, Porter TD (2002) Modification of the nucleotide cofactor-binding site of cytochrome P-450 reductase to enhance turnover with NADH in vivo J Biol Chem 277:48960-48964
80. Xia C, Hamdane D, Shen AL, Choi V, Kasper CB, Pearl NM, Zhang H, Im SC, Waskell L, Kim JJ (2011) Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding J Biol Chem 286:16246-16260
81. Xia C, Panda SP, Marohnic CC, Martasek P, Masters BS, Kim JJ (2011) Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency. Proc Natl Acad Sci U S A 108:13486-13491
82. Page CC, Moser CC, Chen X, Dutton PL (1999) Natural engineering principles of electron tunneling in biological oxidation-reduction Nature 402:47-52
83. Bhattacharyya AK, Lipka JJ, Waskell L, Tollin G (1991) Laser flash photolysis studies of the reduction kinetics of NADPH:cytochrome P-450 reductase, Biochemistry 30:759-765
84. Gutierrez A, Paine M, Wolf CR, Scrutton NS, Roberts GC (2002) Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding Biochemistry 41:4626-4637
85. Zhao Q, Modi S, Smith G, Paine M, McDonagh PD, Wolf CR, Tew D, Lian LY, Roberts GC, Driessen HP (1999) Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1 93 A resolution Protein Sci 8:298-306
86. Kim JJ, Shen AL, Xia C (2012) Structure and catalytic mechanism of NADPH-cytochrome P450 oxidoreductase: a prototype of the diflavin oxidoreductase family of enzymes In: Hille R, Miller S, Palfey B (eds) Handbook of flavoproteins, vol 2. de Gruyter, Berlin, pp 73-101
87. Schilder J, Ubbink M (2013) Formation of transient protein complexes Curr Opin Struct Biol 23:911-918
88. Sem DS, Kasper CB (1995) Effect of ionic strength on the kinetic mechanism and relative rate limitation of steps in the model NADPH-cytochrome P450 oxidoreductase reaction with cytochrome c Biochemistry 34:12768-12774
89. Sevrioukova IF, Li H, Zhang H, Peterson JA, Poulos TL (1999) Structure of a cytochrome P450-redox partner electron-transfer complex Proc Natl Acad Sci U S A 96:1863-1868
90. Sugishima M, Sato H, Higashimoto Y, Harada J, Wada K, Fukuyama K, Noguchi M (2014) Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase Proc Natl Acad Sci U S A 111:2524-2529
91. Lamb DC, Kim Y, Yermalitskaya LV, Yermalitsky VN, Lepesheva GI, Kelly SL, Waterman MR, Podust LM (2006) A second FMN binding site in yeast NADPHcytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases. Structure 14:51-61
92. Gruez A, Pignol D, Zeghouf M, Coves J, Fontecave M, Ferrer JL, Fontecilla-Camps JC (2000) Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxinlike module J Mol Biol 299:199-212
93. Aigrain L, Pompon D, Morera S, Truan G (2009) Structure of the open conformation of a functional chimeric NADPH cytochrome P450 reductase EMBO Rep 10:742-747
94. Hay S, Brenner S, Khara B, Quinn AM, Rigby SE, Scrutton NS (2010) Nature of the energy landscape for gated electron transfer in a dynamic redox protein J Am Chem Soc 132:9738-9745
95. Ellis J, Gutierrez A, Barsukov IL, Huang WC, Grossmann JG, Roberts GC (2009) Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle x-ray scattering J Biol Chem 284:36628-36637
96. Vincent B, Morellet N, Fatemi F, Aigrain L, Truan G, Guittet E, Lescop E (2012) The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR J Mol Biol 420:296-309
97. Pudney CR, Khara B, Johannissen LO, Scrutton NS (2011) Coupled motions direct electrons along human microsomal P450 chains PLoS Biol 9:e1001222
98. Niedenthal R, Riles L, Guldener U, Klein S, Johnston M, Hegemann J (1999) Systematic analysis of S. cerevisiae chromosome VIII genes Yeast 15:1775-1796
99. Benenati G, Penkov S, M�ller-Reichert T, Entchev EV, Kurzchalia TV (2009) Two cytochrome P450s in Caenorhabditis elegans are essential for the organiza tion of eggshell, correct execution of meiosis and the polarization of embryo Mech Dev 126:382-393
100. Rappleye CA, Tagawa A, Le Bot N, Ahringer J, Aroian RV (2003) Involvement of fatty acid pathways and cortical interaction of the pronuclear complex in Caenorhabditis elegans embryonic polarity BMC Dev Biol 3:8
101. Shen AL, O'Leary KA, Kasper CB (2002) Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPHcytochrome P450 oxidoreductase J Biol Chem 277:6536-6541
102. Otto DM, Henderson CJ, Carrie D, Davey M, Gundersen TE, Blomhoff R, Adams RH, Tickle C, Wolf CR (2003) Identification of novel roles of the cytochrome P450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis Mol Cell Biol 23:6103-6116
103. Gu J, Cui H, Behr M, Zhang L, Zhang QY, Yang W, Hinson JA, Ding X (2005) In vivo mechanisms of tissue-selective drug toxicity: effects of liverspecific knockout of the NADPH-cytochrome P450 reductase gene on acetaminophen toxicity in kidney, lung, and nasal mucosa Mol Pharm 67:623-630
104. Gu J, Weng Y, Zhang QY, Cui H, Behr M, Wu L, Yang W, Zhang L, Ding X (2003) Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase J Biol Chem 278:25895-25901
105. Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, Rosewell I, Wolf CR (2003) Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase J Biol Chem 278:13480-13486
106. Stiborov� M, Arlt VM, Henderson CJ, Wolf CR, Kotrbov� V, Moserov� M, Hudecek J, Phillips DH, Frei E (2008) Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse Toxic Appl Pharm 226:318-327
107. Riddick DS, Ding X, Wolf CR, Porter TD, Pandey AV, Zhang QY, Gu J, Finn RD, Ronseaux S, McLaughlin LA, Henderson CJ, Zou L, Fluck CE (2013) NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology Drug Metab Disp 41:12-23
108. Fl�ck CE, Pandey AV, Arlt W, Okuhara K, Verge CF, Jabs EW, Mendon�a BB, Fujieda K, Miller WL (2004) Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome Nat Genet 36:228-230
109. Tee MK, Damm I, Miller WL (2011) Transcriptional regulation of the human P450 oxidoreductase gene: hormonal regulation and influence of promoter polymorphisms Mol Endocrinol 25:715-731
110. Soneda S, Yazawa T, Fukami M, Adachi M, Mizota M, Fujieda K, Miyamoto K, Ogata T (2011) Proximal promoter of the cytochrome P450 oxidoreductase gene: identification of microdeletions involving the untranslated exon 1 and critical function of the SP1 binding sites J Clin Endocrinol Metab 96:E1881-1887
111. Miller WL, Huang N, Pandey AV, Fluck CE, Agrawal V (2005) P450 oxidoreductase deficiency: a new disorder of steroidogenesis Ann N Y Acad Sci 1061:100-108
112. Fluck CE, Pandey AV (2011) Clinical and biochemical consequences of P450 oxidoreductase deficiency Endo Dev 20:63-79
113. Pandey AV, Fluck CE (2013) NADPH P450 oxidoreductase: structure, function, and pathology of diseases Pharmacol Ther 138:229-254
114. Fukami M, Horikawa R, Nagai T, Tanaka T, Naiki Y, Sato N, Okuyama T, Nakai H, Soneda S, Tachibana K, Matsuo N, Sato S, Homma K, Nishimura G, Hasegawa T, Ogata T (2005) Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients J Clin Endocrinol Metab 90:414-426
115. Yanagibashi K, Hall PF (1986) Role of electron transport in the regulation of the lyase activity of C21 side-chain cleavage P-450 from porcine adrenal and testicular microsomes J Biol Chem 261:8429-8433
116. Lin D, Black SM, Nagahama Y, Miller WL (1993) Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase Endocrinology 132:2498-2506
117. Panda SP, Guntur AR, Polusani SR, Fajardo RJ, Gakunga PT, Roman LJ, Masters BS (2013) Conditional deletion of cytochrome P450 reductase in osteoprogenitor cells affects long bone and skull development in mice recapitulating Antley-Bixler syndrome: role of a redox enzyme in development PLoS ONE 8:e75638
118. Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, Jabs EW, Van Vliet G, Sack J, Fluck CE, Miller WL (2005) Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis Am J Hum Genet 76:729-749
119. Marohnic CC, Mart�sek PS, Masters BS (2006) Diminished FAD binding in the Y459H and V492E Antley- Bixler syndrome mutants of human cytochrome P450 reductase J Biol Chem 281:35975-35982
120. Hart SN, Nakamoto K, Wesselman C, Li Y, Zhong XB (2008) Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450- catalyzed drug metabolism Pharmacogenet Genomics 18:11-24
121. Gomes AM, Klein K, Turpeinen M, Schaeffeler E, Schwab M, Zanger UM (2009) Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation Pharmacogenomics 10:579-599
122. Huang N, Agrawal V, Giacomini KM, Miller WL (2008) Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations Proc Natl Acad Sci U S A 105:1733-1738
123. Agrawal V, Huang N, Miller WL (2008) Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19 Pharmacogenet Genomics 18:569-576
124. Agrawal V, Choi JH, Giacomini KM, Miller WL (2010) Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase Pharmacogenet Genomics 20:611-618
125. Sandee D, Morrissey K, Agrawal V, Tam HK, Kramer MA, Tracy TS, Giacomini KM, Miller WL (2010) Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro Pharmacogenomics 20:677-686
126. Subramanian M, Agrawal V, Sandee D, Tam HK, Miller WL, Tracy TS (2012) Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9 1, CYP2C9 2, and CYP2C9 3 Pharmacogenet Genomics 22:590-597
127. 5 Pharmacol Ther 97:139-152
128. 5-cytochrome P450 complex from NMR and mutagenesis data J Biol Chem 288:22080- 22095
129. 5: its function, structure, and membrane topology Biochimie 77:604-620
130. 5 reductase domains of Ncb5or reveals a unique heme pocket and a possible role of the CS domain J Biol Chem 285:30181-30191
131. 5 in N-reductive metabolism in human cells J Biol Chem 288:20228-20237
132. 5 Drug Metab Dispos 12:358-364
133. 5 or heme oxygenase J Biol Chem 276:30885-30891
134. 5 Biochemistry 51:9488-9500
135. 5 profoundly affects hepatic and extrahepatic drug metabolism Mol Pharmacol 78:269-278
136. 5 J Biol Chem 283:31385-31393
137. 5 interactions Arch Biochem Biophys 342:329-337
138. 5 in a reconstituted N-demethylase system containing cytochrome P-450 Biochem Biophys Res Commun 75:420-426
139. 5 inhibits electron transfer from NADPHcytochrome P450 reductase to ferric cytochrome P450 2B4 J Biol Chem 283:217-5225
140. 5 in the in vivo disposition of anticancer and cytochrome P450 probe drugs in mice Drug Metab Dispos 42:1-77
141. 5 in hepatic microsomal mixed-function oxidation reactions Arch Biochem Biophys 143:66-79
142. Page CC, Moser CC, Dutton PL (2003) Mechanism for electron transfer within and between proteins Curr Opin Chem Biol 7:551-556
143. Bonsor DA, Sundberg EJ (2011) Dissecting proteinprotein interactions using directed evolution Biochemistry 50:2394-2402
144. Johansson MP, Blomberg MR, Sundholm D, Wikstrom M (2002) Change in electron and spin density upon electron transfer to haem Biochim Biophys Acta 1553:183-187
145. Clackson T, Wells JA (1995) A hot spot of binding energy in a hormone-receptor interface Science 267:383-386
146. Bogan AA, Thorn KS (1998) Anatomy of hot spots in protein interfaces J Mol Biol 280:1-9
147. Crowley PB, Carrondo MA (2004) The architecture of the binding site in redox protein complexes: implications for fast dissociation Proteins 55:603-612
148. Correia MA, Mannering GJ (1973) Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixedfunction oxidase system of hepatic microsomes II Role of the type I drug-binding site of cytochrome P-450 Mol Pharmacol 9:470-485
149. Zhang H, Gruenke L, Arscott D, Shen A, Kasper CB, Harris DL, Glavanovich M, Johnson R, Waskell L (2003) Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazaFAD T491V cytochrome P450 reductase Biochemistry 42:11594-11603
150. Guengerich FP, Ballou DP, Coon MJ (1975) Purified liver microsomal cytochrome P-450 Electronaccepting properties and oxidation-reduction potential J Biol Chem 250:7405-7414
151. Sligar SG, Cinti DL, Gibson GG, Schenkman JB (1979) Spin state control of the hepatic cytochrome P450 redox potential Biochem Biophys Res Commun 90:925-932
152. Lewis DF, Hlavica P (2000) Interactions between redox partners in various cytochrome P450 systems: functional and structural aspects Biochim Biophy Acta 1460:353-374
153. Guengerich FP (1983) Oxidation-reduction properties of rat liver cytochromes P-450 and NADPHcytochrome P-450 reductase related to catalysis in reconstituted systems Biochemistry 22:2811-2820
154. 5 on the formation of products in cytochrome P-450-catalyzed reactions Drug Metab Dispos 14:89-96
155. 5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer J Biol Chem 273:3158-3165
156. 5 J Biol Chem 271:27438-27444
157. 5 J Biol Chem 270:24707-24718
158. 5 rules uncoupling mechanisms Biochemistry 37:11412-11424
159. 5 linked to NADPH-cytochrome P450 reductase by different membrane-binding segments Arch Biochem Biophys 390:222-234
160. 5 modulation of 17{alpha} hydroxylase and 17-20 lyase CYP17, activities in steroidogenesis J Endocrinol 187:267-274
161. Hasemann CA, Kurumbail RG, Boddupalli SS, Peterson JA, Deisenhofer J (1995) Structure and function of cytochromes P450: a comparative analysis of three crystal structures Structure 3:41-62
162. Poulos TL, Finzel BC, Howard AJ (1987) High-resolution crystal structure of cytochrome P450cam J Mol Biol 195:687-700
163. Scott EE, White MA, He YA, Johnson EF, Stout CD, Halpert JR (2004) Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl) imidazole at 1 9 A{angstrom} resolution: insight into the range of P450 conformations and coordination of redox partner binding J Biol Chem 279:27294-27301
164. 5 J Biol Chem 289:14310-14320
165. 5 interactions revealed by NMR J Biol Chem 288:17008-17018
166. 5 by mass spectrometry and site-directed mutagenesis J Biol Chem 281:20404-20417
167. Koga H, Sagara Y, Yaoi T, Tsujimura M, Nakamura K, Sekimizu K, Makino R, Shimada H, Ishimura Y, Yura K, Go M, Ikeguchi I, Horiuchi T (1993) Essential role of the Arg112 residue of cytochrome P450cam for electron transfer from reduced putidaredoxin FEBS Lett 331:109-113
168. Tripathi S, Li H, Poulos TL (2013) Structural basis for effector control and redox partner recognition in cytochrome P450 Science 340:1227-1230
169. Stayton PS, Sligar SG (1990) The cytochrome P- 450cam binding surface as defined by site-directed mutagenesis and electrostatic modeling Biochemistry 29:7381-7386
170. 5 and putidaredoxin, two effectors of camphor hydroxylase activity Biochemistry 45:3887-3897
171. 5 with flavocytochrome P450 BM3 and its domains Drug Metab Rev 39:599-617
172. 5-cytochrome P-450cam association: a proposed molecular model for a cytochrome P-450cam electron-transfer complex Biochemistry 28:8201-8205
173. Jenkins CM, Waterman MR (1999) Flavodoxin as a model for the P450-interacting domain of NADPH cytochrome P450 reductase Drug Metab Rev 31:195-203
174. Geller DH, Auchus RJ, Mendonca BB, Miller WL (1997) The genetic and functional basis of isolated 17,20-lyase deficiency Nat Genet 17:201-205
175. Hong Y, Rashid R, Chen S (2011) Binding features of steroidal and nonsteroidal inhibitors Steroids 76:802-806
176. 5 Biochem Pharmacol 82:681-691
177. Nikfarjam L, Izumi S, Yamazaki T, Kominami S (2006) The interaction of cytochrome P450 17alpha with NADPH-cytochrome P450 reductase, investigated using chemical modification and MALDITOF mass spectrometry Biochim Biophys Acta 1764:1126-1131
178. Furuya H, Shimizu T, Hirano K, Hatano M, Fujii- Kuriyama Y, Raag R, Poulos TL (1989) Site-directed mutageneses of rat liver cytochrome P-450d: catalytic activities toward benzphetamine and 7-ethoxycoumarin Biochemistry 28:6848-6857
179. Shimizu T, Tateishi T, Hatano M, Fujii-Kuriyama Y (1991) Probing the role of lysines and arginines in the catalytic function of cytochrome P450d by sitedirected mutagenesis Interaction with NADPH-cytochrome P450 reductase J Biol Chem 266:3372- 3375
180. Shen S, Strobel HW (1992) The role of cytochrome P450 lysine residues in the interaction between cytochrome P450IA1 and NADPH-cytochrome P450 reductase Arch Biochem Biophys 294:83-90
181. Shen S, Strobel HW (1993) Role of lysine and arginine residues of cytochrome P450 in the interaction between cytochrome P4502B1 and NADPHcytochrome P450 reductase Arch Biochem Biophys 304:257-265
182. Nakamura K, Horiuchi T, Yasukochi T, Sekimizu K, Hara T, Sagara Y (1994) Significant contribution of arginine-112 and its positive charge of Pseudomonas putida cytochrome P-450cam in the electron transport from putidaredoxin Biochim Biophys Acta 1207:40-48
183. Stayton PS, Sligar SG (1991) Structural microheterogeneity of a tryptophan residue required for efficient biological electron transfer between putidaredoxin and cytochrome P-450cam Biochemistry 30:1845-1851
184. Lee MY, Borgiani P, Johansson I, Oteri F, Mkrtchian S, Falconi M, Ingelman-Sundberg M (2013) High warfarin sensitivity in carriers of CYP2C935 is determined by the impaired interaction with P450 oxidoreductase Pharmacogenomics J Epub prior to publication, 12/10/14 doi:10 1038/tpj 2013 41
185. Mao W, Rupasinghe SG, Zangerl AR, Berenbaum MR, Schuler MA (2007) Allelic variation in the Depressaria pastinacella CYP6AB3 protein enhances metabolism of plant allelochemicals by altering a proximal surface residue and potential interactions with cytochrome P450 reductase J Biol Chem 282:10544-10552
186. Scott EE, He YA, Wester MR, White MA, Chin CC, Halpert JR, Johnson EF, Stout CD (2003) An open conformation of mammalian cytochrome P450 2B4 at 1 6-A resolution Proc Natl Acad Sci U S A 100:13196-13201
187. Wilderman PR, Gay SC, Jang, H-H, Zhang Q, Stout CD, Halpert JR (2012) Investigation by site-directed mutagenesis of the role of cytochrome P450 2B4 non-active-site residues in protein-ligand interactions based on crystal structures of the ligand-bound enzyme FEBS J 279:1607-1620
188. 5-dependent acyl-carbon cleavage activities J Steroid Biochem Mol Biol 92:119-130
189. 5 and its topology in the microsomal membrane Biochim Biophys Acta 997:121-130
190. 5 in eukaryotes J Memb Biol 233:63-72
191. 5 on CYP2E1 and CYP2C19 activities requires anionic residues D58 and D65 Biochemistry 52:210-220
192. 5 with major and minor contributions to CYP3A4-catalyzed steroid and nifedipine oxygenation chemistries Arch Biochem Biophys 541:53- 60
193. 5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17 Biochemistry 45:755-762
194. 5 for studies of its interaction with cytochrome P450 Biochemistry (Moscow) 66:667-681
195. Peterson JA, Ebel RE, O'Keeffe DH, Matsubara T, Estabrook RW (1976) Temperature dependence of cytochrome P-450 reduction A model for NADPHcytochrome P-450 reductase:cytochrome P-450 interaction J Biol Chem 251:4010-4016
196. 5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4 J Biol Chem 282:29766-29776
197. 5 interactions with cytochrome P450: effects on house fly CYP6A1 catalysis Insect Biochem Mol Biol 38:1008-1015
198. 5 J Biol Chem 259:15377-15385
199. 5 to the oxyferrous intermediate of liver microsomal cytochrome P-450 LM2 J Biol Chem 256:9457-9465
200. 5 from rabbit liver Proc Natl Acad Sci U S A 84:11-15
201. 5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli Protein Expr Purif 24:329-337
202. 5: NMR studies of the histidine residues Biochemistry 30:8357-8365
203. 5 J Biol Chem 259:2541-2546
204. 5 as an indicator of changes in heme accessability: preliminary studies with cytochrome P450 3A4 J Inorg Biochem 87:237-244
205. 5 with cytochromes P4503A4 and A: relevance of heme transfer reactions Biochemistry 40:5018-5031
206. 5 in the microsomal metabolism of methoxyflurane Biochem Pharmacol 34:1907-1912
207. 5 on the interaction between cytochrome P450 2B4 and P450 reductase J Inorg Biochem 97:265-275
208. 5 gene causes 46, XY disorder of sex development due to true isolated 17,20 lyase deficiency J Clin Endo Metab 97:E465-475